Evidence map›Paper›PMID 36831358›Full record

ArticleCancers2023

Implementation of Machine Learning Models to Ensure Radiotherapy Quality for Multicenter Clinical Trials: Report from a Phase III Lung Cancer Study.

Huaizhi Geng, Zhongxing Liao, Quynh-Nhu Nguyen, Abigail T Berman, Clifford Robinson, Abraham Wu, Romaine Charles Nichols, Henning Willers, Nasiruddin Mohammed, Pranshu Mohindra and 1 more

Abstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Recent advances in applying machine learning to proton radiotherapy.Biomedical physics & engineering express · 2025
    Pooled it
  2. Article
  3. Article
  4. Uncertainties in outcome modelling in radiation oncology.Physics and imaging in radiation oncology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Huaizhi GengDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Zhongxing LiaoThe University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
Quynh-Nhu NguyenThe University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
Abigail T BermanDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Clifford RobinsonSiteman Cancer Center, Washington University, Saint Louis, MO 63110, USA.
Abraham WuMemorial Sloan-Kettering Cancer Center LAPS, New York, NY 10065, USA.ORCID 0000-0002-2597-7091
Romaine Charles NicholsDepartment of Radiation Oncology, University of Florida Health Science Center-Gainesville, Jacksonville, FL 32610, USA.
Henning WillersDana-Farber/Partners Cancer Care LAPS, Boston, MA 02215, USA.
Nasiruddin MohammedNorthwestern Medicine Cancer Center Warrenville, Warrenville, IL 60555, USA.
Pranshu MohindraGreenebaum Cancer Center, University of Maryland, Baltimore, MD 21201, USA.
Ying XiaoDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NRG Oncology Network Group Operations Center - GY9 BIQSFP Reports/BudgetsU10CA180868 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI NORMAN WOLMARK · 2014 to 2026
$206.8M
IROC: Enhancing local enrolling site radiological data capture capabilities for NCTN trialsU24CA180803 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI Thomas J. FitzGerald, MICHAEL V KNOPP · 2014 to 2026
$116.2M
WASHINGTON UNIVERSITY / SITEMAN CANCER CENTER LEAD ACADEMIC SITEUG1CA233339 · NCI · WASHINGTON UNIVERSITY · PI NANCY L BARTLETT, Clifford Grant Robinson · 2019 to 2026
$11.3M
Risk prediction and longitudinal assessment of cardiotoxicity and functional capacity trajectory in NSCLC patientsR01HL157273 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LIAO, ZHONGXING · 2021 to 2025
$3.8M
NCI NIH HHS P30 CA008748NCI NIH HHS U10 CA180868NCI NIH HHS U24 CA180803NCI NIH HHS U24CA180803NCI NIH HHS UG1 CA233339NHLBI NIH HHS R01 HL157273
6 · The paper itself

Abstract

The outcome of the patient and the success of clinical trials involving RT is dependent on the quality assurance of the RT plans. Knowledge-based Planning (KBP) models using data from a library of high-quality plans have been utilized in radiotherapy to guide treatment. In this study, we report on the use of these machine learning tools to guide the quality assurance of multicenter clinical trial plans. The data from 130 patients submitted to RTOG1308 were included in this study. Fifty patient cases were used to train separate photon and proton models on a commercially available platform based on principal component analysis. Models evaluated 80 patient cases. Statistical comparisons were made between the KBP plans and the original plans submitted for quality evaluation. Both photon and proton KBP plans demonstrate a statistically significant improvement of quality in terms of organ-at-risk (OAR) sparing. Proton KBP plans, a relatively emerging technique, show more improvements compared with photon plans. The KBP proton model is a useful tool for creating proton plans that adhere to protocol requirements. The KBP tool was also shown to be a useful tool for evaluating the quality of RT plans in the multicenter clinical trial setting.

Indexed as

clinical trial quality assuranceknowledge-based planningnon-small-cell lung cancerradiotherapy

Identifiers

PMID36831358
PMCPMC9953775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.